TP53 and neoplasm: Additionally, according to Gherman et al. (2012), the p53 expression in the OXP treated cells results in antitumor effects that include inhibition of cell cycle progression and induction of apoptosis through the modulation of the expression of apoptosis and cell-cycle-related genes, and the sensitization of tumor cells to chemotherapy.